Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

recurrent neuroblastoma

Known as: Relapsed Neuroblastoma, neuroblastoma, recurrent 
The reemergence of neuroblastoma after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
INTRODUCTION Children with neuroblastoma have widely divergent outcomes, ranging from cure in >90% of patients with low risk… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
BACKGROUND Early-phase trials in patients with recurrent neuroblastoma historically used an objective "response" of measureable… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE Survival after neuroblastoma relapse is poor. Understanding the relationship between clinical and biologic features and… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE Most neuroblastomas initially respond to therapy but many relapse with chemoresistant disease. p53 mutations are rare in… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The Italian Neuroblastoma Registry was investigated to describe 781 children with neuroblastoma experiencing tumour recurrence… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
p53 mutations have been reported in cell lines derived from relapsed neuroblastoma tumors. We hypothesize that functional… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
INTRODUCTION (131)I-meta iodobenzylguanidine ((131)I-mIBG) therapy is established palliation for relapsed neuroblastoma. The… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
p53 mutations are rare in neuroblastomas at diagnosis perhaps accounting for their initial response to therapy, but advanced… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE The analogue 131I-metaiodobenzylguanidine (MIBG), which is specifically targeted to neuroblastoma cells, may provide more… Expand
Is this relevant?
1998
1998
Tumor cells that have been genetically modified to express immunostimulatory genes will induce effective antitumor responses in a… Expand
Is this relevant?